sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
27-May-2016 16:06
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 376-400 out of 1258.

<< < 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>

Public Release: 2-Nov-2015
US and Mexico must jointly combat Chagas disease
Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

Contact: Jeff Falk
jfalk@rice.edu
713-348-6775
Rice University

Public Release: 2-Nov-2015
BIDMC researchers win 2015 Dvorak Young Investigator Award
Beth Israel Deaconess Medical Center scientists Anders Berg, M.D., Ph.D., and David Friedman, M.D., whose research is exploring genetic changes underlying kidney disease, have been awarded the 2015 Dvorak Young Investigator Award.

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center

Public Release: 2-Nov-2015
Canadian Medical Association Journal
Substantial differences in obstetric care for First Nations women in Canada: BC study
There are substantial differences in obstetric care provided to First Nations women compared with women in the general population, and these differences may contribute to higher infant mortality in First Nations populations, according to research published in Canadian Medical Association Journal.

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116
Canadian Medical Association Journal

Public Release: 1-Nov-2015
Expert Review of Vaccines
Could self-disseminating vaccines cut off emerging infectious diseases at source?
An expert review identifies state-of-the-art of self-disseminating vaccines as a new and potentially powerful strategy to circumvent diseases such as Ebola at the animal source before their establishment as the next human pandemic

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth

Public Release: 29-Oct-2015
PLOS Neglected Tropical Diseases
UTMB researchers help discover simple, affordable diagnostic kit for chikungunya
A novel and affordable diagnostic test for chikungunya will soon be available thanks to the work of researchers at the University of Texas Medical Branch at Galveston in partnership with a commercial lab.

Contact: Christopher Smith Gonzalez
chrissmi@UTMB.EDU
409-772-8790
University of Texas Medical Branch at Galveston

Public Release: 29-Oct-2015
AIDS
HIV/AIDS deaths are down in South Africa -- But most are still unacknowledged
After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 28-Oct-2015
Journal of Insect Science
Researchers compare 'natural' mosquito repellents to DEET
Researchers at New Mexico State University tested 10 commercially available products for their effectiveness at repelling mosquitoes. The results were published in the Journal of Insect Science.

Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America

Public Release: 27-Oct-2015
Lancet Infectious Diseases
RI Hospital researcher confirms praziquantel safe after first trimester
Rhode Island Hospital researchers confirmed that praziquantel to treat schistosomiasis is safe to give pregnant women after the first trimester. The finding could prove critical to the care of pregnant and lactating women with schistosomiasis who are denied praziquantel. The study was published in The Lancet Infectious Diseases.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases

Contact: Beth Bailey
bbailey@lifespan.org
401-444-6421
Lifespan

Public Release: 27-Oct-2015
The BMJ
Thousands die from snakebite each year as anti-venom treatment out of reach
Snakebite claims thousands of lives in the world's poorest communities every year but remains a 'forgotten killer,' according to a new editorial published in the British Medical Journal.

Contact: Jane Gardner
gardner.j@unimelb.edu.au
61-411-758-984
University of Melbourne

Public Release: 27-Oct-2015
ASTMH 64th Annual Meeting
New studies show nobel prize-winning drug that knocks out parasitic worms could have second act fighting malaria
A workhorse of a drug that a few weeks ago earned its developers a Nobel prize for its success in treating multiple tropical diseases is showing early promise as a novel and desperately needed tool for interrupting malaria transmission, according to new findings presented today at the American Society of Tropical Medicine and Hygiene Annual Meeting.

Contact: Preeti Singh
psingh@burness.com
301-280-5722
Burness

Public Release: 26-Oct-2015
ASTMH 64th Annual Meeting
American Journal of Tropical Medicine and Hygiene
New study unravels mystery of why deadly tick disease appears to be surging, yet fatalities have not
A mild disease spread by the aggressive Lone star tick that is now colonizing large swaths of the United States is being mistaken for Rocky Mountain spotted fever, according to a new study from scientists at the US Centers for Disease Control and Prevention. The findings may indicate a key reason reports of infections with the potentially fatal pathogen appear to be surging but deaths are not, according to researchers.

Contact: Bridget DeSimone
bdesimone@burness.com
301-280-5735
Burness

Public Release: 26-Oct-2015
Journal of Medical Entomology
Male mosquitoes lured to traps by sounds of female wing-beats
Male mosquitoes have been found to zero in on inexpensive traps that broadcast sound that is similar in frequency to the sound that is produced by the wing-beats of female mosquitoes -- a discovery that may lead to better mosquito control in developing countries.
National Health and Medical Research Council

Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America

Public Release: 26-Oct-2015
The Lancet
Stopping tuberculosis requires new strategy
Unless there is a major shift in the way the world fights tuberculosis -- from a reliance on biomedical solutions to an approach that combines biomedical interventions with social actions -- the epidemic and drug resistance will worsen, say researchers at Harvard T.H. Chan School of Public Health.
Wellcome Trust, National Institutes of Health

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-8413
Harvard T.H. Chan School of Public Health

Public Release: 22-Oct-2015
Cell Reports
How parasites take a bigger bite
A team of international scientists led by the Research Institute of the McGill University Health Centre uncovered an important mechanism behind Leishmania, a deadly parasitic disease transmitted by sandflies. In a new study published today in Cell Reports, researchers described how key molecules known as exosomes, boost the process by which the Leishmania parasite infects humans and other mammals. These findings could lead to the development of new potential vaccine targets and diagnostic tools.
Canadian Institutes of Health Research

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-934-1934 x71381
McGill University Health Centre

Public Release: 22-Oct-2015
New England Journal of Medicine
NIH-funded study reveals why malaria vaccine only partially protected children, infants
Using new, highly sensitive genomic sequencing technology, an international team of researchers has found new biological evidence to help explain why the malaria vaccine candidate RTS,S/AS01 (called RTS,S) provided only moderate protection among vaccinated children during clinical testing. The researchers, funded in part by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, found that genetic variability in the surface protein targeted by the RTS,S vaccine likely played a significant role.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Emily Mullin
emily.mullin@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 22-Oct-2015
Journal of Virological Methods
Bio-Rad's Droplet Digital™ PCR (ddPCR™) proves highly reproducible at identifying viral RNA mutations in clinical samples
Researchers show that droplet digital PCR is more sensitive, precise and reproducible at measuring viral RNA mutation rates in clinical samples than real-time PCR.

Contact: Ken Li
kli@chempetitive.com
312-532-4675
Chempetitive Group

Public Release: 22-Oct-2015
PLOS Pathogens
Interrupting the transmission cycle: A protein required for dengue virus infection of mosquitoes
An estimated 2 billion people are at risk for being bitten by Aedes mosquitoes and infected with the dengue virus (DENV). A study published on Oct. 22 in PLOS Pathogens introduces a candidate target for a transmission-blocking vaccine that interferes with virus infection of the mosquito after it feeds on the blood of infected hosts (such a vaccine would be a valuable complement to traditional DENV vaccines in development that seek to prevent human infection).

Contact: Tonya Colpitts
tonya.colpitts@uscmed.sc.edu
803-216-3421
PLOS

Public Release: 21-Oct-2015
American Society of Tropical Medicine & Hygiene
New England Journal of Medicine
Genomic study sheds light on protective effects of malaria vaccine candidate
An international team of researchers has used cutting edge genomic methods to uncover key biological insights that help explain the protective effects of the world's most advanced malaria vaccine candidate, RTS,S/AS01 (RTS,S). Applying highly sensitive sequencing technology to more patient samples than previously tested, the team was able to determine that genetic variation in the protein targeted by RTS,S influences the vaccine's ability to ward off malaria in young children.
NIh/National Institute of Allergy and Infectious Diseases, Bill & Melinda Gates Foundation, PATH Malaria Vaccine Initiative

Contact: Paul Goldsmith
paulg@broadinstitute.org
617-714-8600
Broad Institute of MIT and Harvard

Public Release: 21-Oct-2015
Parasites & Vectors
Leprosy and elephantiasis: New cases could be prevented in 10 years
The life chances of over one billion people could be improved through examining the transmission of nine neglected tropical diseases (NTDs), an international consortium of researchers has argued. Leprosy, Elephantiasis and Sleeping Sickness are among nine tropical diseases targeted. Neglected tropical diseases affect over one billion people worldwide.
Bill and Melinda Gates Foundation, The Novartis Foundation

Contact: Tom Frew
a.t.frew@warwick.ac.uk
44-024-767-75910
University of Warwick

Public Release: 21-Oct-2015
The Lancet
Worldwide shift in heart medication delivery required: Study
Many people in the world who need essential heart medicine do not get it, even in rich countries, says new research published today in the medical journal The Lancet. A radical change is required in how such medicines are provided and preventative care organized in health care systems, the authors say.
Population Health Research Institute, Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, AstraZeneca, Sanofi-Aventis, Boehringer Ingelheim, Servier, GlaxoSmithKline, and others

Contact: Susan Emigh
emighs@mcmaster.ca
905-525-9140 x22555
McMaster University

Public Release: 20-Oct-2015
PLOS Pathogens
Cancer-causing parasite may accelerate wound healing
James Cook University scientists have found a cancer-causing, parasitic worm could help patients recover from their wounds.

Contact: Alistair Bone
alistair.bone@jcu.edu.au
61-747-814-942
James Cook University

Public Release: 20-Oct-2015
Nature Communications
NIH study reveals risk of drug-resistant malaria spreading to Africa
Drug-resistant forms of Plasmodium falciparum, the deadliest species among malaria parasites, are able to infect the type of mosquito that is the main transmitter of malaria in Africa, according to findings from scientists at NIAID. The discovery suggests Africa -- where malaria will cause an estimated 400,000 deaths in 2015 -- is more at risk for drug-resistant malaria infections than previously thought, which could further compromise efforts to prevent and eliminate the disease.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 20-Oct-2015
Angewandte Chemie International Edition
First synthetic model of a bacterial outer membrane will support antibiotic development
Scientists have developed a model of the outer membrane of the bacteria E. coli (Escherichia coli) providing a brand new tool for developing new antibiotics and other drugs in the fight against infections.
Wellcome Trust

Contact: Karen Bidewell/Helen Rae
press.office@ncl.ac.uk
44-019-120-86972
Newcastle University

Public Release: 19-Oct-2015
Malaria Journal
New approach toward a broad spectrum malaria vaccine
Malaria affects millions of people worldwide. Plasmodium falciparum enolase participates in parasite invasion of host red blood cells and mosquito midgut epithelium. Anti-enolase antibodies interfere with the invasion, inhibiting parasite growth and transmission. A pentapeptide insert of parasite enolase, conserved in all Plasmodia species, but absent from host enolases, shows considerable protection against malaria when displayed on Archaeal gas vesicle nanoparticles. A vaccine based on this motif could confer protection against all malaria parasites.
Tata Institute of Fundamental Research, Department of Atomic Energy, Government of India, National Institutes of Health, Bill and Melinda Gates Foundation

Contact: Gotam Jarori
gkjarori@gmail.com
91-996-940-4805
Tata Institute of Fundamental Research

Public Release: 19-Oct-2015
Research!America to honor leaders in medical and health research advocacy
Research!America's 20th annual Advocacy Awards will honor exceptional advocates for research whose achievements in their fields have brought hope to patients worldwide. The event will take place on Wednesday, March 16, 2016, at the Andrew W. Mellon Auditorium in Washington, D.C.

Contact: Anna Briseno
571-482-2737
Research!America

Showing releases 376-400 out of 1258.

<< < 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>